Reported 1,572,421 shares, down 133,727 (7.8%) from the prior quarter.
Reported value -57.1%; share count -7.8% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-09-30 | 24720000 |
| 2021-12-31 | 19906000 |
| 2022-03-31 | 22757000 |
| 2022-06-30 | 16448000 |
| 2022-09-30 | 24757000 |
| 2022-12-31 | 10629566 |
| 2023-03-31 | 12246934 |
| 2023-06-30 | 14397642 |
| 2023-09-30 | 15838913 |
| 2023-12-31 | 27464808 |
| 2024-03-31 | 28846295 |
| 2024-06-30 | 34693467 |
| 2024-09-30 | 35461654 |
| 2024-12-31 | 24258047 |
| 2025-03-31 | 36371022 |
| 2025-06-30 | 35378930 |
| 2025-09-30 | 38076105 |
| 2025-12-31 | 60629492 |
| 2026-03-31 | 76411406 |
| 2026-06-30 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q2 2026 | Reduced | 0 | -3,795,897 (-100.0%) | 0 | $0 | 2026-08-07 | |
| Q1 2026 | Added | 3,795,897 | +41,749 (1.1%) | < 0.01% | $76,411,406 | 2026-05-13 | |
| Q4 2025 | Added | 3,754,148 | +628,031 (20.1%) | < 0.01% | $60,629,492 | 2026-02-12 | |
| Q3 2025 | Reduced | 3,126,117 | -3,377 (-0.1%) | < 0.01% | $38,076,105 | 2025-11-12 | |
| Q2 2025 | Reduced | 3,129,494 | -22,241 (-0.7%) | < 0.01% | $35,378,930 | 2025-08-12 | |
| Q1 2025 | Added | 3,151,735 | +287,739 (10.0%) | < 0.01% | $36,371,022 | 2025-05-02 | |
| Q4 2024 | Reduced | 2,863,996 | -198,323 (-6.5%) | < 0.01% | $24,258,047 | 2025-02-07 | |
| Q3 2024 | New | 3,062,319 | +3,062,319 (0.0%) | < 0.01% | $35,461,654 | 2024-11-13 | |
| Q2 2024 | Added | 2,945,116 | +512,882 (21.1%) | < 0.01% | $34,693,467 | 2024-08-13 | |
| Q1 2024 | Added | 2,432,234 | +190,209 (8.5%) | < 0.01% | $28,846,295 | 2024-05-10 | |
| Q4 2023 | Added | 2,242,025 | +597,278 (36.3%) | < 0.01% | $27,464,808 | 2024-02-13 | |
| Q3 2023 | Added | 1,644,747 | +45,009 (2.8%) | < 0.01% | $15,838,913 | 2023-11-13 | |
| Q2 2023 | Added | 1,599,738 | +41,604 (2.7%) | < 0.01% | $14,397,642 | 2023-08-11 | |
| Q1 2023 | Reduced | 1,558,134 | -14,287 (-0.9%) | < 0.01% | $12,246,934 | 2023-05-12 | |
| Q4 2022 | Reduced | 1,572,421 | -133,727 (-7.8%) | < 0.01% | $10,629,566 | 2023-02-13 | |
| Q3 2022 | Added | 1,706,148 | +34,653 (2.1%) | < 0.01% | $24,757,000 | 2022-11-14 | |
| Q2 2022 | Added | 1,671,495 | +127,468 (8.3%) | < 0.01% | $16,448,000 | 2022-08-12 | |
| Q1 2022 | Added | 1,544,027 | +39,407 (2.6%) | < 0.01% | $22,757,000 | 2022-05-12 | |
| Q4 2021 | Added | 1,504,620 | +87,978 (6.2%) | < 0.01% | $19,906,000 | 2022-02-10 | |
| Q3 2021 | Reduced | 1,416,642 | -9,780 (-0.7%) | < 0.01% | $24,720,000 | 2021-11-09 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
114 managers reported KALVISTA PHARMACEUTICALS IN for Q4 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| TCG Crossover Management LLC | New | 3,395,495 | +3,395,495 | 4.05% | $22,953,546 | 1 qtr |
| Frazier Life Sciences Management L P | Added | 3,238,859 | +1,666,667 | 1.36% | $21,894,687 | 4 qtrs |
| TANG CAPITAL MANAGEMENT LLC | Added | 3,196,446 | +1,396,446 | 3.14% | $21,607,975 | 4 qtrs |
| VR Adviser LLC | New | 2,916,667 | +2,916,667 | 3.32% | $19,716,669 | 1 qtr |
| BlackRock Inc This report | Reduced | 1,572,421 | -133,727 | < 0.01% | $10,629,566 | 24 qtrs |
| FMR LLC | Added | 1,311,002 | +152,617 | < 0.01% | $8,862,374 | 16 qtrs |
| JEFFERIES FINANCIAL GROUP INC | New | 1,200,000 | +1,200,000 | 0.06% | $8,112,000 | 1 qtr |
| VANGUARD GROUP INC | Added | 1,152,673 | +2,812 | < 0.01% | $7,792,070 | 25 qtrs |
| SUVRETTA CAPITAL MANAGEMENT LLC | Reduced | 1,072,302 | -634,798 | 0.3% | $7,248,762 | 12 qtrs |
| ADAGE CAPITAL PARTNERS GP L L C | Reduced | 1,064,339 | -15,000 | 0.02% | $7,194,932 | 18 qtrs |
Filing details and methodology As reported
- Report period
- December 31, 2022
- Filed
- February 13, 2023
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 1,538,859
- Shared
- 0
- None
- 33,562
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.